Paclitaxel: all 2,138 studies that test it
Page 12 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.
- A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid TumorCompletedNCT04046016Early Phase 1
- COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
- Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)CompletedNCT04031703Phase 3
- VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical CancerStatus unknownNCT04017377Not applicable
- A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in ChinaActive, not recruitingNCT04015778Phase 2
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPCStatus unknownNCT04015661Phase 2
- Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT04004871Phase 2
- A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTCStatus unknownNCT04004234Phase 1/2
- PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisActive, not recruitingNCT04000906Phase 1
- Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerStatus unknownNCT03994107Phase 1/2
- Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLCStatus unknownNCT03991403Phase 3
- S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesStatus unknownNCT03990103Phase 2
- Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )Status unknownNCT03975270Phase 2
- Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal AdenocarcinomaStatus unknownNCT03966118Phase 2
- Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLCActive, not recruitingNCT03965468Phase 2
- Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast CancerStatus unknownNCT03959397Phase 2
- Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.CompletedNCT03944304Phase 2
- Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract CancerStatus unknownNCT03943043Phase 1/2
- Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03942068Phase 2
- Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial CancerActive, not recruitingNCT03935256Phase 2
- Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerActive, not recruitingNCT03932409Phase 1
- Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerStatus unknownNCT03929094Phase 2
- Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous AngiosarcomaActive, not recruitingNCT03921008Phase 1/2
- Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory StudyStatus unknownNCT03919253Phase 2
- High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03908333Phase 1/2
- Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast CancerStatus unknownNCT03907800Phase 2
- Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT03885219Phase 2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast CancerCompletedNCT03872791Phase 1/2
- Improve Checkpoint-blockade Response in Advanced Urothelial CancerCompletedNCT03871036Phase 1/2
- Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve FertilityTerminatedNCT03852979Phase 2
- Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerStatus unknownNCT03850769Phase 2
- AO-176 in Multiple Solid Tumor MalignanciesCompletedNCT03834948Phase 1/2
- Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenWithdrawnNCT03834571Phase 2
- The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract AdenocarcinomaCompletedNCT03830606Phase 2
- A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )Status unknownNCT03825328Phase 2
- Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric CancerWithdrawnNCT03818997Phase 2
- Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian CancerStatus unknownNCT03818282Phase 2
- Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03815461Phase 2
- FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
- Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerTerminatedNCT03802058Phase 2
- Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric AdenocarcinomaStatus unknownNCT03801668Phase 3
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
- A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric CancerStatus unknownNCT03788226Phase 3
- Apatinib Combined With POF for Second-line Treatment of Gastric AdenocarcinomaStatus unknownNCT03788174Phase 2
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive, not recruitingNCT03768063Phase 3
- Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric CancerWithdrawnNCT03766607Phase 2
- TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT03756818Phase 1
- GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel StudyCompletedNCT03751761Phase 1/2
- Paclitaxel and TAK-228 in Urothelial CarcinomaStatus unknownNCT03745911Phase 2
- Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast CancerStatus unknownNCT03735082Phase 2
- ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsCompletedNCT03725436Phase 1
- FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/PaclitaxelCompletedNCT03723967Phase 2
- A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic MalignanciesCompletedNCT03719326Phase 1
- A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT03718624Phase 2
- DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BCActive, not recruitingNCT03716180Phase 1
- Study of the Combination of Apatinib and POFStatus unknownNCT03707639Phase 2
- A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction CancerTerminatedNCT03707028Phase 1/2
- An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaWithdrawnNCT03704077Phase 2
- Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal CytologyStatus unknownNCT03703089Phase 1
- Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
- Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung CancerWithdrawnNCT03699033Phase 2
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03697239Phase 1/2
- First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRICompletedNCT03693677Phase 2
- Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerStatus unknownNCT03693248Phase 3
- Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerTerminatedNCT03690739Phase 3
- Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerStatus unknownNCT03647514Not applicable
- The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT03647280Not applicable
- Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT03639246Phase 1
- Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6CompletedNCT03618758Phase 1/2
- Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant ChemotherapyWithdrawnNCT03607955Phase 1
- Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing SurgerySuspendedNCT03604991Phase 2/3
- SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerStatus unknownNCT03603756Phase 2
- Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast CancerCompletedNCT03600090Phase 1
- Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT03587311Phase 2
- Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic CancerTerminatedNCT03585062Phase 2
- Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric CancerActive, not recruitingNCT03579784Phase 2
- Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerStatus unknownNCT03579004Phase 2
- The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.CompletedNCT03577704Phase 1/2
- Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?Status unknownNCT03570437Phase 2
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
- QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2
- QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineWithdrawnNCT03554109Phase 2
- Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid ModelStatus unknownNCT03544047Not applicable
- Scheduling Nab-paclitaxel With GemcitabineCompletedNCT03529175Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerTerminatedNCT03520686Phase 3
- Paclitaxel-Avelumab for AngiosarcomaStatus unknownNCT03512834Phase 2
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsCompletedNCT03507491Phase 1
- An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast CancerCompletedNCT03505528Phase 1
- Pembrolizumab and Paclitaxel in Hypermutated Breast CancerCompletedNCT03492918Phase 2
- A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant AscitesStatus unknownNCT03475615Phase 3
- Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial CarcinomaCompletedNCT03464734Phase 2
- A Phase 1/2 Study of FS118 in Patients With Advanced MalignanciesTerminatedNCT03440437Phase 1/2
- Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingStatus unknownNCT03412643Phase 2
- Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube CancerStatus unknownNCT03410784Phase 2